Investor Summary
Fund Strategy
FUND PERFORMANCE AS OF 31st March 2026
| ANNUALIZED SINCE INCEPTION | QUARTERLY | YTD |
|---|---|---|
| 13.1% | -13.3% | -13.3% |
| ANNUALIZED SINCE INCEPTION | QUARTERLY | YTD |
|---|---|---|
| 13.1% | -13.3% | -13.3% |
Edgewood Management delivered a disappointing Q1 2026 return of -13.3% versus -4.3% for the S&P 500, primarily driven by valuation compression in growth stocks rather than fundamental deterioration. The firm's portfolio companies delivered strong fundamentals with average earnings growth of 32% year-over-year, significantly outpacing broader market growth of 19%. The underperformance was attributed to market pricing of theoretical AI-driven disruption concerns, particularly affecting software companies, despite better-than-expected earnings results. Edgewood maintains conviction in their concentrated 22-stock portfolio of high-quality businesses with durable competitive advantages. The firm believes many portfolio companies are well-positioned to benefit from AI adoption, with companies like MSCI expecting AI to triple investment capacity and Netflix using AI to improve content production efficiency. Management views current market conditions as creating meaningful appreciation opportunities between current prices and intrinsic values, and expects outperformance when markets refocus on fundamentals rather than speculative themes.
Focus on high-quality large cap growth companies with durable competitive advantages, consistent growth, and strong management that can leverage AI to reinforce their competitive moats.
The firm believes the market is currently overgeneralizing disruption risk, creating a meaningful appreciation opportunity between current prices and intrinsic values. They expect the strategy to historically outperform when markets refocus on fundamentals rather than speculative themes.
| Date | Letter | Tickers | Keywords | Pitches | Quick Takes |
|---|---|---|---|---|---|
| Apr 25 2026 | 2026 Q1 | ASML, AVGO, AXON, BSX, BX, FICO, INTU, ISRG, LLY, MSCI, NFLX, NOW, NVDA, SNPS, SPOT, VRTX | AI, earnings, growth, large cap, semiconductors, software, technology, Valuations | - | Edgewood's Q1 2026 underperformance of -13.3% was driven by AI-related valuation compression in growth stocks, not fundamental deterioration. Portfolio companies delivered 32% average earnings growth while the market priced theoretical disruption concerns. The firm maintains conviction in high-quality businesses positioned to benefit from AI adoption and sees current dislocation as creating meaningful appreciation opportunities. |
| Dec 31 2025 | 2025 Q4 | ASML, AVGO, AXON, BSX, BX, FICO, INTU, ISRG, LLY, MSCI, NFLX, NOW, NVDA, SHOP, SNPS, SPGI, SPOT, TDG, V, VRTX | AI, growth, healthcare, large cap, Quality, semiconductors, software, technology |
AXON APH |
Edgewood delivered 7% net returns in 2025 while portfolio companies generated 27% EPS growth, creating stored alpha opportunity. Strong fundamentals across AI infrastructure, healthcare, and enterprise software holdings position the strategy for outperformance as market leadership broadens. Recent additions Axon and Amphenol capitalize on AI-driven secular growth trends. |
| Sep 30 2025 | 2025 Q3 | ABNB, ASML, AVGO, BSX, BX, FICO, INTU, ISRG, LLY, MSCI, NFLX, NOW, NVDA, SHOP, SNPS, SPGI, SPOT, TDG, V, VRTX | AI, growth, healthcare, large cap, semiconductors, software, technology |
FICO LLY ASML SNPS ISRG BSX |
Edgewood's concentrated growth strategy underperformed in Q3 due to stock-specific issues, not fundamental deterioration. The firm maintains high conviction in AI infrastructure buildout (28% of portfolio) and quality growth companies. Management personally invested additional capital in September, demonstrating confidence. Active position building during market dislocations positions the portfolio for AI adoption and secular growth themes. |
| Jun 30 2025 | 2025 Q2 | ABNB, ASML, AVGO, BSX, BX, CPRT, FICO, INTU, ISRG, LLY, MSCI, NFLX, NOW, NVDA, SHOP, SNPS, SPGI, SPOT, TDG, TTD, V, VRTX | AI, growth, healthcare, large cap, Medical Devices, semiconductors, technology |
AVGO FICO BSX AVGO FICO |
Edgewood delivered 15.9% Q2 returns led by NVIDIA and Netflix, while initiating three new positions in Boston Scientific, Broadcom, and Fair Isaac. The concentrated portfolio of 22 quality growth companies is positioned for AI secular trends and semiconductor market expansion to $1T+ by 2030, with reduced turnover expected ahead. |
| Mar 31 2025 | 2025 Q1 | AAPL, AMZN, GOOGL, META, MSFT, NVDA, ORCL | AI, inflation, productivity, rates, small caps, Trade Policy, Valuations |
SHOP SPOT |
Markets are flourishing in an era of policy abundance with robust corporate earnings, AI investment boom, and favorable fiscal/monetary backdrop. All asset classes posted positive third quarter returns. Key opportunities include small cap stocks given extreme valuation discounts and international equities. Main risks are labor market stress, tariff-driven inflation, and geopolitical fragmentation from deglobalization trends. |
| QUARTER | THEMES | TAGS |
|---|---|---|
| 2026 Q1 |
AIPortfolio companies are leveraging AI to enhance their competitive moats and drive efficiency gains. MSCI expects AI to triple investment capacity over 3-4 years, Netflix is using AI to make content production faster and cheaper, and Spotify leverages AI for enhanced personalization. The firm believes companies with deep domain expertise, complex embedded platforms, and proprietary datasets will be advantaged in an AI-enabled world. |
Artificial Intelligence Efficiency Competitive Moats Datasets Automation |
SemiconductorsStrong positioning in semiconductor ecosystem with holdings in NVIDIA, ASML, and Broadcom. NVIDIA reports exceptionally strong demand with primary bottleneck being customer data center infrastructure. ASML sees structural industry shifts driving strong demand into 2026-2027. Broadcom has secured multi-year deals with key custom silicon customers. |
Chips Data Centers Memory Equipment Foundries | |
GrowthPortfolio companies delivered average earnings growth of 32% year-over-year during the quarter, significantly outpacing the S&P 500's 19% growth. The firm maintains focus on high-quality businesses with consistent growth characteristics including growing cash flow, high profit margins, and recurring revenue models. |
Earnings Revenue Margins Cash Flow Quality | |
| 2025 Q4 |
AIAI infrastructure buildout drives strong performance for portfolio companies like NVIDIA, Broadcom, and ASML. AI Era Plan from Axon represents fastest booked product to date. Draft One AI tool generates police reports in minutes with 50%+ time savings. |
Infrastructure Software Automation Enterprise Cloud |
GrowthPortfolio delivered 27% average EPS growth versus 7% stock performance, creating stored alpha opportunity. Companies demonstrate consistent earnings execution with 29% YoY growth in most recent quarter. |
Earnings Fundamentals Compounding Quality Performance | |
SemiconductorsNVIDIA, Broadcom, and ASML represent core AI infrastructure holdings. Semiconductor companies benefit from AI server demand requiring greater connector content versus traditional servers. |
AI Infrastructure Memory Equipment Foundries | |
SoftwareSoftware revenue percentage drives gross margin expansion with every 5% increase adding 130bps of margin. AI accelerating cloud demand and creating new monetization opportunities through tools like Draft One. |
SaaS Cloud Margins Recurring Enterprise | |
| 2025 Q3 |
AIEdgewood maintains significant exposure to AI infrastructure buildout representing 28% of portfolio. The firm has developed a comprehensive AI framework spanning infrastructure enablement, proprietary data applications, and productivity enhancements. They see encouraging signs that AI is beginning to broaden beyond infrastructure to the proprietary data and application layer. |
Infrastructure Applications Productivity Computing Data |
SemiconductorsPortfolio includes major semiconductor positions including NVIDIA, ASML, Broadcom, and Synopsys. NVIDIA continues accelerating product release cycles driving exponential performance improvements. ASML's lithography machines enable AI chip manufacturing advancements. Broadcom leads hyperscale custom chip design. |
Chips Manufacturing Design Equipment Computing | |
CloudServiceNow is targeting $1B in AI Now Assist annual contract value by 2026 with consumption-based monetization. The firm sees cloud infrastructure as foundational to AI deployment and data processing capabilities across their portfolio companies. |
Infrastructure Software Computing Services Platforms | |
BiotechnologyEli Lilly represents a major position focused on diabetes and obesity markets with large global patient populations that remain largely underserved. The company launched TuneLab platform for AI-enabled drug discovery and maintains a rich pipeline across therapeutic categories. |
Pharmaceuticals Drug Discovery Diabetes Obesity Pipeline | |
Medical DevicesPortfolio includes Intuitive Surgical and Boston Scientific. Intuitive Surgical's latest robot offers 10,000x more computing power leveraging AI for case insights. Boston Scientific incorporates AI into software, imaging and monitoring sensors for diagnostics. |
Robotics Surgery Diagnostics Innovation Healthcare | |
| 2025 Q2 |
AIAI spending remains a robust secular trend with significant growth opportunities. Broadcom is positioned to benefit from the $250B+ AI chip market through custom silicon and networking equipment for AI datacenter buildouts. NVIDIA continues to drive AI compute with strong performance in the quarter. |
Custom Silicon Datacenter Compute Networking TPUs |
SemiconductorsThe semiconductor market is expected to grow from $655B today to $1T+ by 2030 driven by AI compute, networking and digital communications. Broadcom's diversified semiconductor business is well-positioned to benefit from hyperscaler investment in custom silicon. |
Custom Silicon Hyperscaler Networking Compute Growth | |
Medical DevicesBoston Scientific operates in an attractive $70B medical device market estimated to grow 8-9% in 2025. The company benefits from procedure-based sales driving durable revenue streams and advances in technology enabling safer, more effective treatments. |
Procedures Innovation Growth Healthcare Technology | |
CloudBroadcom's software business centered around VMware is positioned to benefit from private cloud adoption. 53% of senior IT leaders say private cloud is top priority for deploying new workloads, with 84% using private cloud for traditional enterprise applications. |
Private Cloud VMware Enterprise Infrastructure Software | |
| 2025 Q1 |
AIHyperscaler capital expenditure growth has been booming, soaring 75% in 2025 as leading US technology companies spend tens of billions on GPUs and AI model development. AI enthusiasts believe we are on the cusp of a paradigmatic shift upward in productivity that will transform the economy and reshape work. AI-related stocks have accounted for 75% of S&P 500 returns, 80% of earnings growth, and 90% of capital spending growth since ChatGPT launched. |
GPUs Hyperscalers Productivity Capital Expenditure Technology |
Trade PolicyTrade policy continues to follow a somewhat erratic path, but uncertainty around tariffs has diminished notably. The announcement of trade deals suggests the overall tariff rate will come in at approximately 14%, well below initial indications. Tariff receipts have been rising with the Customs and Border Protection agency collecting $31 billion in both August and September. |
Tariffs Trade Deals Customs Import Costs | |
RatesThe Federal Open Market Committee cut its Fed funds rate by one quarter percentage point in September and signaled two additional rate cuts by year end. The FOMC has shifted its focus to its full employment mandate and is poised to cut rates further. Lower rates stimulate the economy directly by lowering interest expenses and indirectly by creating a lower threshold for returns on investment projects. |
Fed Funds Rate Cuts Monetary Policy Interest Expenses | |
Small CapsRelative valuations for US small cap stocks are striking, with the valuation gap versus US large cap stocks the widest it has been since the 1990s. Small cap stocks are more sensitive to interest rates, more cyclical in nature, bigger beneficiaries of lower interest rates, and more domestically focused, thus beneficiaries of the policy set-up. After a long stretch of under-performance, small cap stocks may be poised to lead the charge. |
Valuation Gap Interest Rate Sensitivity Domestic Focus Cyclical | |
InflationUsing the Fed's preferred measure, core Personal Consumption Expenditures rose 2.9% over the past 12 months, significantly higher than the 2% target. The last time core PCE was at target was March 2021. There are concerns about tariff-related inflation impacts and stimulative monetary and fiscal policy initiatives potentially accelerating economic growth and contributing to greater inflation impulse. |
Core PCE Fed Target Tariff Impact Policy Stimulus |
| Date | Pitch Type | Author | Ticker | Company | Industry | Sub Industry | Bull / Bear | Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | Fund Letters | Alan Breed | AXON | Axon Enterprise, Inc. | Industrials | Aerospace & Defense | Bull | NASDAQ | Artificial Intelligence, international expansion, Keyence, Margins, Public safety, recurring revenue, SaaS, Subscriptions | Login |
| Dec 31, 2025 | Fund Letters | Alan Breed | APH | Amphenol Corporation | Information Technology | Electronic Components | Bull | New York Stock Exchange | Acquisitions, Aerospace, Artificial Intelligence, Automation, Connectors, data centers, Defense, semiconductors | Login |
| Sep 30, 2025 | Fund Letters | Alan Breed | ISRG | Intuitive Surgical, Inc. | Health Care | Health Care Equipment | Bull | NASDAQ | Installed base, Margins, Medical devices, Procedure Growth, recurring revenue, robotics, Surgical Systems | Login |
| Sep 30, 2025 | Fund Letters | Alan Breed | BSX | Boston Scientific Corporation | Health Care | Health Care Equipment | Bull | New York Stock Exchange | Afib, capital deployment, Electrophysiology, Margins, Medical devices, organic growth, pipeline | Login |
| Sep 30, 2025 | Fund Letters | Alan Breed | FICO | Fair Isaac Corporation | Information Technology | Application Software | Bull | New York Stock Exchange | analytics, credit scoring, market share, Mortgage, Pricing power, recurring revenue, Regulation | Login |
| Sep 30, 2025 | Fund Letters | Alan Breed | LLY | Eli Lilly and Company | Health Care | Pharmaceuticals | Bull | New York Stock Exchange | Clinical trials, Diabetes, drug pipeline, earnings growth, GLP-1, Obesity, valuation | Login |
| Sep 30, 2025 | Fund Letters | Alan Breed | ASML | ASML Holding N.V. | Information Technology | Semiconductor Materials & Equipment | Bull | New York Stock Exchange | Artificial Intelligence, Capital equipment, Euv, Lithography, market share, secular growth, semiconductors | Login |
| Sep 30, 2025 | Fund Letters | Alan Breed | SNPS | Synopsys, Inc. | Information Technology | Application Software | Bull | NASDAQ | Artificial Intelligence, backlog, Eda, Export restrictions, Intellectual Property, recurring revenue, Semiconductor Design | Login |
| Jun 30, 2025 | Fund Letters | Edgewood Management | FICO | Fair Isaac Corp. | Software | Application Software | Bull | NYSE | auto loans, capital return, Consumer credit, credit scoring, Financial Analytics, Mortgage, Pricing power, Regulatory Moat, risk management, royalty model | Login |
| Jun 30, 2025 | Fund Letters | Alan Breed | AVGO | Broadcom Inc. | Information Technology | Semiconductors | Bull | NASDAQ | AI infrastructure, capital return, custom silicon, Free Cash Flow, hyperscalers, Software | Login |
| Jun 30, 2025 | Fund Letters | Edgewood Management | BSX | Boston Scientific Corp. | Health Care Equipment & Supplies | Health Care Equipment | Bull | NYSE | Ablation Technology, Atrial Fibrillation, cardiovascular, Electrophysiology, Healthcare Equipment, innovation, M&A, Medical devices, Minimally Invasive, Procedure-Based Revenue | Login |
| Jun 30, 2025 | Fund Letters | Alan Breed | FICO | Fair Isaac Corporation | Information Technology | Application Software | Bull | New York Stock Exchange | buybacks, credit scoring, Mortgage Volumes, network effects, Pricing power, Regulatory risk | Login |
| Jun 30, 2025 | Fund Letters | Edgewood Management | AVGO | Broadcom Inc. | Semiconductors & Semiconductor Equipment | Semiconductors | Bull | NASDAQ | AI chips, capital return, custom silicon, datacenter, high margins, hyperscaler, infrastructure software, M&A, Private Cloud, semiconductors, Vmware | Login |
| Mar 31, 2025 | Fund Letters | Alan Breed | SHOP | Shopify Inc. | Information Technology | Internet & Direct Marketing Retail | Bull | New York Stock Exchange | B2b, e-commerce, Free Cash Flow, Gross margin, international expansion, Payments, platform, POS | Login |
| Mar 31, 2025 | Fund Letters | Alan Breed | SPOT | Spotify Technology S.A. | Communication Services | Interactive Media & Services | Bull | New York Stock Exchange | advertising, Free Cash Flow, Gross margin, monetization, Personalization, Podcasts, Streaming, Subscriptions | Login |
| TICKER | COMMENTARY |
|---|---|
| NFLX | Netflix Inc. added 2.0% to portfolio weighting. Using AI to make content production faster & cheaper, improving quality and efficiency. Q1 total security return of 2.5% with 0.5% contribution to performance. |
| ASML | ASML Holding NV trimmed by 2.5% but remains 8.1% portfolio weighting. CEO reports structural industry shifts drive strong demand for ASML's technology into 2026-2027. Q1 total security return of 23.6% with 1.7% contribution to performance. |
| NVDA | NVIDIA Corp. both added 0.5% and trimmed 1.0% during quarter, maintaining 7.4% weighting. CFO reports demand is exceptionally strong, with primary bottleneck being customer data center infrastructure. 98% most recent quarter YoY EPS growth. |
| AVGO | Broadcom Corp. maintained at 6.9% weighting. CEO reports secured multi-year deals with the world's key custom silicon customers. 28% most recent quarter YoY EPS growth. |
| SNPS | Synopsys Inc. maintained at 5.9% weighting. CEO reports outlook for FY26 is solid, with core EDA and ANSYS both tracking for double-digit growth. AI chips increase design complexity & need for tools. |
| AXON | Axon Enterprises Inc. added 2.0% to 5.6% weighting. CFO reports position as law enforcement hardware provider gives company the right to win AI/software. Hardware entrenchment plus dataset creates value. |
| MSCI | MSCI Inc. added 1.0% to 5.1% weighting. CEO and CFO report AI-driven efficiency has potential to triple investment capacity over 3-4 years, reinforcing competitive moat. |
| SHOP | Shopify Inc. added 0.5% to 4.7% weighting. AI lowers store creation friction and increases need for tools, payments, fulfillment, expanding SHOP surface area and TAM. |
| ISRG | Intuitive Surgical Inc. maintained at 4.6% weighting. CEO reports leveraging its unique surgical dataset to build a defensible moat with AI-powered tools. |
| LLY | Eli Lilly & Co. trimmed 2.5% to 4.1% weighting. CEO reports continuing to innovate within and beyond the weight-loss franchise. 46% most recent quarter YoY EPS growth. |
| SPOT | Spotify Technologies Inc. added 1.0% to 4.0% weighting. Co-CEO and CFO report AI acts as strategic accelerator that leverages SPOT's dataset to enhance personalization. |
| FICO | Fair Isaac Corp. added 0.5% to 3.7% weighting. CEO reports confidence in direct licensing opportunity and superior scoring product relative to Vantage. AI lacks explainability required by regulators for Fair Lending Laws. |
| INTU | Intuit Inc. maintained at 3.2% weighting. CEO and CFO report strong execution in core tax business, fueled by focus on Assisted Tax opportunity. |
| BSX | Boston Scientific Corp. both added 1.0% and trimmed 0.5% to 3.1% weighting. CEO reports well-positioned to execute on updated financial framework of 10%+ revenue growth. |
| NOW | ServiceNow Inc. added 1.0% to 2.8% weighting. CEO and President report strong AI monetization drives larger renewals and add-on sales, overcoming federal slowdown. |
| VRTX | Vertex Pharmaceuticals Inc. maintained at 2.6% weighting. CEO reports commercial execution is broadening beyond CF, with strong launch momentum for Journavx. |
| BX | Blackstone Inc. trimmed 2.0% to 1.9% weighting. AI-driven efficiency and productivity support BX portfolio company fundamentals through diversified investments into innovation. |
| Ticker | Put/Call | Amount Bought | Shares Bought | % Change | Weight % |
|---|---|---|---|---|---|
| No Recent Buys Data | |||||
| Ticker | Put/Call | Amount Sold | Shares Sold | % Change | Weight % | Status |
|---|---|---|---|---|---|---|
| No Recent Sells Data | ||||||
| Industry | Prev Quarter % | Current Quarter % | Change |
|---|---|---|---|
| No industry data available | |||